Evaluation of the use of REAC protocols in comparison with conventional therapies or placebo as a treatment for reducing symptoms of Post-Covid Syndrome in adults
Not Applicable
Recruiting
- Conditions
- Symptom Assessment, General Symptoms, Statistics on Sequelae and Disability3154357843
- Registration Number
- RBR-77jbq56
- Lead Sponsor
- niversidade Federal do Amapá
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Adult volunteers, over 18; of both genders; with previous clinical and laboratory diagnosis of Covid-19; with or without comorbidities; presenting complaints of persistent symptoms of Covid-19 for at least 14 days after recovery from acute Covid-19; with or without pulmonary sequelae by Covid-19 upon presentation of Computed Tomography.
Exclusion Criteria
Volunteer children or teenagers, under 18 years old; without previous clinical and laboratory diagnosis of Covid-19; presenting limiting conditions of attendance or use of a pacemaker; report of untrustworthy symptoms to the clinical picture of post-Covid sequelae or reports longer than the 12 weeks period after recovery from the acute phase of Covid-19.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method